Zi-fan Lu-Zifan
State Key Laboratory Of Cancer Biology
Xi'an, China
Xi'an, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Establishment of patient-derived organoids and a characterization based drug discovery platform for treatment of gastric cancer.
Journal: Cancer cell international
Published: February 02, 2024
Retraction Note: Azoramide, a novel regulator, favors adipogenesis against osteogenesis through inhibiting the GLP-1 receptor-PKA-β-catenin pathway.
Journal: Stem cell research & therapy
Published: September 29, 2023
QKI deficiency leads to osteoporosis by promoting RANKL-induced osteoclastogenesis and disrupting bone metabolism.
Journal: Cell death & disease
Published: November 25, 2019
MOTS-c inhibits Osteolysis in the Mouse Calvaria by affecting osteocyte-osteoclast crosstalk and inhibiting inflammation.
Journal: Pharmacological research
Published: April 03, 2019
Earlier changes in mice after D-galactose treatment were improved by mitochondria derived small peptide MOTS-c.
Journal: Biochemical and biophysical research communications
Published: March 22, 2019
MOTS-c peptide regulates adipose homeostasis to prevent ovariectomy-induced metabolic dysfunction.
Journal: Journal of molecular medicine (Berlin, Germany)
Published: July 27, 2018
A new vaccine targeting RANKL, prepared by incorporation of an unnatural Amino acid into RANKL, prevents OVX-induced bone loss in mice.
Journal: Biochemical and biophysical research communications
Published: March 25, 2018
Metformin protects bone mass in ultra-high-molecular-weight polyethylene particle-induced osteolysis by regulating osteocyte secretion.
Journal: Journal of bone and mineral metabolism
Published: November 09, 2017
Last Updated: 09/26/2026